Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Antibody responses in the nose after intranasal versus intramuscular influenza vaccination
NL-OMON60469Phase 4Completed
- Sponsor
- Leiden University Medical Center
- Start
- Sep 2025
- Modality
- Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of live attenuated influenza vaccine and Fluzone Trivalent in influenza (2 arms), sponsored by Leiden University Medical Center. Primary endpoint: Fold change in influenza-specific IgA in nasal fluid at day 21. Started Sep 2025; status: completed.
02
Drugs
live attenuated influenza vaccineFluzone Trivalent
03
Conditions
influenza
Beyond the preview
Go deeper on NL-OMON60469.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON60469.